Case Study: Pfizer’s Arena acquisition – A $6.7B deal
Posted on20 Dec 2021
Tagsacquisition, acquisition in pharma, largest ever pharma deal, pfizer, Pfizer strategic deal, pharma acquisition, pharma deal, pharma strategic deal
Comments0
Pfizer will acquire Arena Pharmaceuticals for $6.7 billion to expand its pipeline of immuno-inflammatory disease drugs in development. Why Pfizer acquired Arena?... Read More
Case Study: Acquisition of Otrexup – A Drug Device Combination
Posted on17 Dec 2021
Comments0
Assertio Holdings, Inc., a leading commercial pharmaceutical company bringing differentiated products to patients, today announced it has acquired Otrexup (methotrexate), a drug... Read More
Case Insight: Natco acquires Dash Pharmaceuticals
Posted on17 Dec 2021
Comments0
NATCO Pharma, through its affiliates, is proposing to enter into an agreement to acquire Dash Pharmaceuticals LLC subject to satisfactory completion of... Read More
Acquisition in Pharma: Why Astellas to acquire Xyphos Biosciences?
Astellas Pharma Inc. has agreed to acquire Xyphos Biosciences, Inc. Why Astellas acquired Xyphos? With the acquisition Astellas will gain Xyphos’ novel... Read More
Pharma acquisition case study: Lundbeck to acquire Alder BioPharmaceuticals for US$ 1.95 billion
H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals (Alder) announced a definitive agreement for Lundbeck to acquire Alder. About the deal: Under the... Read More
Case Analysis: Insight on AbbVie’s acquisition of Allergan
On June 25, 2019, AbbVie Inc. and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie... Read More
Bristol-Myers Squibb to acquire Celgene in deal worth $74 billion
Posted on07 Jan 2019
Comments0
BMS - Celgene acquisition deal
2018 Pharma Deal: Sanofi’s agreement to buy Bioverati @ $10.9 billion
Posted on18 Dec 2018
TagsBioverati, global pharma deals, global pharma licensing deal, pharma acquisition, pharma deal, Sanofi
Comments0
Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive... Read More
2018 Pharma Deal: Novartis’ acquisition of AveXis: $8.1 billion
Posted on18 Dec 2018
TagsAveXis, global pharma deals, global pharma licensing deal, novartis, pharma acquisition, pharma deal
Comments0
Novartis has agreed to acquire the US-based Nasdaq-listed clinical stage gene therapy company for USD 218 per share or a total of... Read More
Consequences and progress of Takeda-Shire Buyout
Takeda announced in April it would buy Shire in the largest-ever overseas acquisition by a Japanese company. Although Shire is based in... Read More